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The cumulative risk of term stillbirth, i.e., the death of a
fetus in utero on or after 37 weeks 0 days of gestation,
increases with increasing gestational age throughout the
term period (37 weeks 0 days – 41 weeks 6 days)[1].
Despite this fact, a rule – called the 39-week rule –
was established in 2009 that restricts labor induction in
the 37th and 38th week of pregnancy (i.e., in the “early-
term period”) unless an accepted/approved “indication”
is present (Table 1). [2] The 39-week rule is now a strict
clinical guideline that is enforced by professional organi-
zations, governmental agencies and the medical insur-
ance industry[3-5]. The 39-week rule means that a
pregnant woman who has an identifiable risk factor for
stillbirth but who does not have an accepted “indication”
for labor induction has no choice but to wait until at
least 39 weeks 0 days before she can be delivered.
Unfortunately, the strict application of the 39-week rule
has probably led to hundreds early-term stillborn infants
in the US over the past few years[6,7].
The purpose of this presentation was to disclose major
problems with the development, application and ethics
of the 39-week rule. Firstly, the evidentiary foundation
of the 39-week rule is composed almost entirely of
observational studies (i.e., Level 2 evidence) that contain
a variety of serious flaws including confounding by indi-
cation, [8-10] confounding by situation, [10-12] selection
bias, [13] misclassification bias, [14] incorrect modelling,
[8-10] and the use of data from pre-37 week deliveries
[10,15] and/or pre-labor cesarean deliveries.[16,17]. Sec-
ondly, these observational studies report magnitudes of
association between early-term non-indicated labor
induction and adverse birth outcomes (as measured in
relative risk [RR], odds ratio [OR]) that are not large
enough to be used to claim the identification of an
underlying “truth” (i.e., that early-term non-indicated
labor inductions per se cause adverse birth outcomes).
[18] Thirdly, the evidentiary foundation ignores recent
higher-quality research that suggests that early-term
non-indicated labor induction might provide significant
benefits[19-21]. Fourthly, the 39-week rule was created
by a process that chose the relatively arbitrary “cut-
point” of 39 weeks 0 days of gestation [22], failed to
consider the potential importance of intermediate levels
of prenatal risk [23], ignored the opinions and experi-
ence of non-academic providers [24], and excluded
input from the general public. Fifthly, the 39-week rule
ignores the primary importance of the medical ethical
principle of Autonomy [25,26]. Autonomy represents
the concept that a patient, given that she has a reason-
ably good understanding of risk and benefit, has the
right to either request or refuse any given reasonable
medical therapy. The 39-week rule prevents a woman
from requesting and receiving a non-indicated induction
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Table 1 Accepted Indications for Labor Induction
Late-term pregnancy (> 41 weeks 0 days of gestation)
Severe fetal growth restriction (fetus not growing, < 5%)
Rupture of membranes without labor
Severe pre-eclampsia (hypertension of pregnancy)
Chorio-amnionitis (amniotic fluid infection)
Failed antenatal testing (possible fetal compromise)
Significant oligohydramnios (AFI < 6)
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of labor in the early-term period of pregnancy. The rea-
son given for this restriction on patient autonomy in the
setting of early-term non-indicated labor induction is
the application of another medical ethical principle
called Beneficence [2]. Beneficence represents the con-
cept that a provider has the obligation to provide a
patient with the best treatment(s) available. However, as
noted above, it is unclear if the use of labor induction in
the absence of an accepted “indication” in the early-term
period of pregnancy provides more harm than benefit.
The 39-week rule is not supported by the type of evi-
dentiary foundation that is generally needed to restrict
patient Autonomy [27,28].
In summary, the 39-week rule is not supported by
high-quality evidence, its strict application unjustifiably
obstructs patient autonomy, and it may actually cause
harm in the form of early-term stillbirth. Because of
these problems the 39-week rule should be modified,
made optional, or withdrawn. Patients should be able to
request and receive early-term labor induction if they
believe that such an intervention is in the best interest
of themselves and/or their fetus.
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